$200K - $250K*
The Market Access Pipeline & Launch Excellence team delivers competitive access strategies, frameworks, and tactics across US managed market segments for assigned Novartis pipeline and BD&L compounds; develops impactful product positioning and compelling value propositions for development phase assets that optimize enduring and profitable access and patient affordability.
The team is divided into 3 key functions: BD&L, early pipeline, and phase 3 market access support.
1. BD&L Function: The right person will have a solid analytical background with an interest in market opportunity assessments and forecasting.
2. Early Pipeline Support: The right person will have a deep understanding of the US managed market environment that they can draw on to inform clinical trial design and early opportunity assessments across the Pharma portfolio, which may include assets that fall within any of the following franchises: Respiratory; Immunology, Hepato
Valid through: 2020-4-3